{"entity":{"type":"insider","cik":"0001303811","url":"/insider/0001303811","json_url":"/insider/0001303811.json","name":"Kassberg Thomas Richard","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":31,"first":"2006-11-02","last":"2025-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Kassberg Thomas Richard","source":"filing","n_filings":31,"first_seen":"2006-11-02","last_seen":"2025-03-04"}],"transactions":[{"id":4263692,"accession":"0000950170-25-032802","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-032802","line_url":"/filing/0000950170-25-032802#line-3","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & EVP)","role_mark":"O","role_mark_label":"Officer (CBO & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6028.0,"shares_display":"6,028","price_per_share":42.1,"price_display":"42.10","price_state":"stated","total_value":253778.8,"total_display":"253,778.80","total_whole":"253,779","shares_owned_after":265238.0,"shares_owned_after_display":"265,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":2274865,"accession":"0000950170-24-029780","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-029780","line_url":"/filing/0000950170-24-029780#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & EVP)","role_mark":"O","role_mark_label":"Officer (CBO & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11509.0,"shares_display":"11,509","price_per_share":49.93,"price_display":"49.93","price_state":"stated","total_value":574644.37,"total_display":"574,644.37","total_whole":"574,644","shares_owned_after":252823.0,"shares_owned_after_display":"252,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-12","scope":"insider"},{"id":2674643,"accession":"0000950170-24-026661","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-026661","line_url":"/filing/0000950170-24-026661#line-4","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & EVP)","role_mark":"O","role_mark_label":"Officer (CBO & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1011.0,"shares_display":"1,011","price_per_share":53.76,"price_display":"53.76","price_state":"stated","total_value":54351.36,"total_display":"54,351.36","total_whole":"54,351","shares_owned_after":264332.0,"shares_owned_after_display":"264,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"},{"id":8155970,"accession":"0001209191-23-053487","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-053487","line_url":"/filing/0001209191-23-053487#line-2","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & EVP)","role_mark":"O","role_mark_label":"Officer (CBO & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39878.0,"shares_display":"39,878","price_per_share":32.78,"price_display":"32.78","price_state":"stated","total_value":1307200.84,"total_display":"1,307,200.84","total_whole":"1,307,201","shares_owned_after":246860.0,"shares_owned_after_display":"246,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-23","filed_date":"2023-10-24","scope":"insider"},{"id":8019268,"accession":"0001209191-23-016046","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-016046","line_url":"/filing/0001209191-23-016046#line-4","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & EVP)","role_mark":"O","role_mark_label":"Officer (CBO & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1968.0,"shares_display":"1,968","price_per_share":45.27,"price_display":"45.27","price_state":"stated","total_value":89091.36,"total_display":"89,091.36","total_whole":"89,091","shares_owned_after":250254.0,"shares_owned_after_display":"250,254","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-03","scope":"insider"},{"id":6920173,"accession":"0001209191-22-018829","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-018829","line_url":"/filing/0001209191-22-018829#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & EVP)","role_mark":"O","role_mark_label":"Officer (CBO & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10281.0,"shares_display":"10,281","price_per_share":67.01,"price_display":"67.01","price_state":"stated","total_value":688929.81,"total_display":"688,929.81","total_whole":"688,930","shares_owned_after":227559.0,"shares_owned_after_display":"227,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-15","scope":"insider"},{"id":6368397,"accession":"0001209191-22-015806","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-015806","line_url":"/filing/0001209191-22-015806#line-2","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & EVP)","role_mark":"O","role_mark_label":"Officer (CBO & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2374.0,"shares_display":"2,374","price_per_share":66.62,"price_display":"66.62","price_state":"stated","total_value":158155.88,"total_display":"158,155.88","total_whole":"158,156","shares_owned_after":213840.0,"shares_owned_after_display":"213,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-03","scope":"insider"},{"id":4487501,"accession":"0001209191-21-060754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-060754","line_url":"/filing/0001209191-21-060754#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & EVP)","role_mark":"O","role_mark_label":"Officer (CBO & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":286.0,"shares_display":"286","price_per_share":81.14,"price_display":"81.14","price_state":"stated","total_value":23206.04,"total_display":"23,206.04","total_whole":"23,206","shares_owned_after":216266.0,"shares_owned_after_display":"216,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-14","filed_date":"2021-10-18","scope":"insider"},{"id":4535528,"accession":"0001209191-21-031384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-031384","line_url":"/filing/0001209191-21-031384#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & EVP)","role_mark":"O","role_mark_label":"Officer (CBO & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":363.0,"shares_display":"363","price_per_share":113.69,"price_display":"113.69","price_state":"stated","total_value":41269.47,"total_display":"41,269.47","total_whole":"41,269","shares_owned_after":106818.0,"shares_owned_after_display":"106,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-06","filed_date":"2021-05-10","scope":"insider"},{"id":5374704,"accession":"0001209191-21-017567","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-017567","line_url":"/filing/0001209191-21-017567#line-3","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & EVP)","role_mark":"O","role_mark_label":"Officer (CBO & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4572.0,"shares_display":"4,572","price_per_share":138.17,"price_display":"138.17","price_state":"stated","total_value":631713.24,"total_display":"631,713.24","total_whole":"631,713","shares_owned_after":107181.0,"shares_owned_after_display":"107,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":2975735,"accession":"0001209191-20-055178","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-055178","line_url":"/filing/0001209191-20-055178#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & EVP)","role_mark":"O","role_mark_label":"Officer (CBO & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":262.0,"shares_display":"262","price_per_share":87.98,"price_display":"87.98","price_state":"stated","total_value":23050.76,"total_display":"23,050.76","total_whole":"23,051","shares_owned_after":101478.0,"shares_owned_after_display":"101,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-14","filed_date":"2020-10-16","scope":"insider"},{"id":9270858,"accession":"0001209191-19-025125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-025125","line_url":"/filing/0001209191-19-025125#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & EVP)","role_mark":"O","role_mark_label":"Officer (CBO & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":832.0,"shares_display":"832","price_per_share":65.52,"price_display":"65.52","price_state":"stated","total_value":54512.64,"total_display":"54,512.64","total_whole":"54,513","shares_owned_after":89474.0,"shares_owned_after_display":"89,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-05","filed_date":"2019-04-17","scope":"insider"},{"id":8233894,"accession":"0000899243-15-003146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-003146","line_url":"/filing/0000899243-15-003146#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & Senior Vice President)","role_mark":"O","role_mark_label":"Officer (CBO & Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3334.0,"shares_display":"3,334","price_per_share":109.7,"price_display":"109.70","price_state":"stated","total_value":365739.8,"total_display":"365,739.80","total_whole":"365,740","shares_owned_after":70204.0,"shares_owned_after_display":"70,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-12","filed_date":"2015-08-14","scope":"insider"},{"id":8778776,"accession":"0000899243-15-001039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-001039","line_url":"/filing/0000899243-15-001039#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & Senior Vice President)","role_mark":"O","role_mark_label":"Officer (CBO & Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3334.0,"shares_display":"3,334","price_per_share":102.12,"price_display":"102.12","price_state":"stated","total_value":340468.08,"total_display":"340,468.08","total_whole":"340,468","shares_owned_after":73538.0,"shares_owned_after_display":"73,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-08","filed_date":"2015-07-10","scope":"insider"},{"id":8602718,"accession":"0001209191-15-052749","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-052749","line_url":"/filing/0001209191-15-052749#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & Senior Vice President)","role_mark":"O","role_mark_label":"Officer (CBO & Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3334.0,"shares_display":"3,334","price_per_share":88.19,"price_display":"88.19","price_state":"stated","total_value":294025.46,"total_display":"294,025.46","total_whole":"294,025","shares_owned_after":76872.0,"shares_owned_after_display":"76,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-10","filed_date":"2015-06-12","scope":"insider"},{"id":8249500,"accession":"0001209191-15-043271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-043271","line_url":"/filing/0001209191-15-043271#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & Senior Vice President)","role_mark":"O","role_mark_label":"Officer (CBO & Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3334.0,"shares_display":"3,334","price_per_share":72.04,"price_display":"72.04","price_state":"stated","total_value":240181.36,"total_display":"240,181.36","total_whole":"240,181","shares_owned_after":75806.0,"shares_owned_after_display":"75,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-13","filed_date":"2015-05-15","scope":"insider"},{"id":8793022,"accession":"0001209191-15-033574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-033574","line_url":"/filing/0001209191-15-033574#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & Senior Vice President)","role_mark":"O","role_mark_label":"Officer (CBO & Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":58.02,"price_display":"58.02","price_state":"stated","total_value":193380.66,"total_display":"193,380.66","total_whole":"193,381","shares_owned_after":79140.0,"shares_owned_after_display":"79,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-08","filed_date":"2015-04-10","scope":"insider"},{"id":8247816,"accession":"0001209191-15-026074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-026074","line_url":"/filing/0001209191-15-026074#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & Senior Vice President)","role_mark":"O","role_mark_label":"Officer (CBO & Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":56.3,"price_display":"56.30","price_state":"stated","total_value":187647.9,"total_display":"187,647.90","total_whole":"187,648","shares_owned_after":82473.0,"shares_owned_after_display":"82,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-11","filed_date":"2015-03-13","scope":"insider"},{"id":8080348,"accession":"0001209191-15-013780","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-013780","line_url":"/filing/0001209191-15-013780#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & Senior Vice President)","role_mark":"O","role_mark_label":"Officer (CBO & Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":54.3117,"price_display":"54.31","price_state":"stated","total_value":181020.8961,"total_display":"181,020.90","total_whole":"181,021","shares_owned_after":85806.0,"shares_owned_after_display":"85,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-11","filed_date":"2015-02-13","scope":"insider"},{"id":8811149,"accession":"0001209191-15-004710","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-004710","line_url":"/filing/0001209191-15-004710#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & Senior Vice President)","role_mark":"O","role_mark_label":"Officer (CBO & Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":51.51,"price_display":"51.51","price_state":"stated","total_value":171682.83,"total_display":"171,682.83","total_whole":"171,683","shares_owned_after":89139.0,"shares_owned_after_display":"89,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-14","filed_date":"2015-01-16","scope":"insider"},{"id":6977527,"accession":"0001209191-14-074945","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-074945","line_url":"/filing/0001209191-14-074945#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & Senior Vice President)","role_mark":"O","role_mark_label":"Officer (CBO & Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":40.22,"price_display":"40.22","price_state":"stated","total_value":134053.26,"total_display":"134,053.26","total_whole":"134,053","shares_owned_after":92472.0,"shares_owned_after_display":"92,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-12","scope":"insider"},{"id":6206239,"accession":"0001209191-14-068768","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-068768","line_url":"/filing/0001209191-14-068768#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & Senior Vice President)","role_mark":"O","role_mark_label":"Officer (CBO & Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":41.85,"price_display":"41.85","price_state":"stated","total_value":139486.05,"total_display":"139,486.05","total_whole":"139,486","shares_owned_after":95805.0,"shares_owned_after_display":"95,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-14","scope":"insider"},{"id":6652602,"accession":"0001209191-14-062967","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-062967","line_url":"/filing/0001209191-14-062967#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & Senior Vice President)","role_mark":"O","role_mark_label":"Officer (CBO & Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":53.26,"price_display":"53.26","price_state":"stated","total_value":177515.58,"total_display":"177,515.58","total_whole":"177,516","shares_owned_after":99138.0,"shares_owned_after_display":"99,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-08","filed_date":"2014-10-10","scope":"insider"},{"id":7035063,"accession":"0001209191-14-057808","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-057808","line_url":"/filing/0001209191-14-057808#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & Senior Vice President)","role_mark":"O","role_mark_label":"Officer (CBO & Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":54.82,"price_display":"54.82","price_state":"stated","total_value":182715.06,"total_display":"182,715.06","total_whole":"182,715","shares_owned_after":102471.0,"shares_owned_after_display":"102,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-10","filed_date":"2014-09-12","scope":"insider"},{"id":6296349,"accession":"0001209191-14-056033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-056033","line_url":"/filing/0001209191-14-056033#line-2","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & Senior Vice President)","role_mark":"O","role_mark_label":"Officer (CBO & Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":550000.0,"total_display":"550,000.00","total_whole":"550,000","shares_owned_after":105804.0,"shares_owned_after_display":"105,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-03","filed_date":"2014-09-04","scope":"insider"},{"id":6296346,"accession":"0001209191-14-056033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-056033","line_url":"/filing/0001209191-14-056033#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (CBO & Senior Vice President)","role_mark":"O","role_mark_label":"Officer (CBO & Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBO & Senior Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":52.82,"price_display":"52.82","price_state":"stated","total_value":528200.0,"total_display":"528,200.00","total_whole":"528,200","shares_owned_after":115804.0,"shares_owned_after_display":"115,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":7032411,"accession":"0001209191-14-006662","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-006662","line_url":"/filing/0001209191-14-006662#line-1","is_derivative":false,"issuer_cik":"0001303811","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001303811","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (Chief Business Officer & SVP)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer & SVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer & SVP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":31500.0,"total_display":"31,500.00","total_whole":"31,500","shares_owned_after":94350.0,"shares_owned_after_display":"94,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-30","filed_date":"2014-02-03","scope":"insider"},{"id":8298981,"accession":"0001209191-07-072420","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-072420","line_url":"/filing/0001209191-07-072420#line-2","is_derivative":false,"issuer_cik":"0001087432","issuer_name":"INTERMUNE INC","issuer_ticker":"ITMN","issuer_name_source":null,"issuer_url":"/issuer/0001087432","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9375.0,"shares_display":"9,375","price_per_share":13.4509,"price_display":"13.45","price_state":"stated","total_value":126102.1875,"total_display":"126,102.19","total_whole":"126,102","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-28","filed_date":"2007-12-31","scope":"insider"},{"id":7426250,"accession":"0001209191-07-058234","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-058234","line_url":"/filing/0001209191-07-058234#line-1","is_derivative":false,"issuer_cik":"0001087432","issuer_name":"INTERMUNE INC","issuer_ticker":"ITMN","issuer_name_source":null,"issuer_url":"/issuer/0001087432","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4289.0,"shares_display":"4,289","price_per_share":19.308,"price_display":"19.31","price_state":"stated","total_value":82812.012,"total_display":"82,812.01","total_whole":"82,812","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-10","filed_date":"2007-10-12","scope":"insider"},{"id":7453582,"accession":"0001209191-07-042014","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-07-042014","line_url":"/filing/0001209191-07-042014#line-4","is_derivative":false,"issuer_cik":"0001087432","issuer_name":"INTERMUNE INC","issuer_ticker":"ITMN","issuer_name_source":null,"issuer_url":"/issuer/0001087432","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12900.0,"shares_display":"12,900","price_per_share":27.2404,"price_display":"27.24","price_state":"stated","total_value":351401.16,"total_display":"351,401.16","total_whole":"351,401","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-10","filed_date":"2007-07-11","scope":"insider"},{"id":7453576,"accession":"0001209191-07-042014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-042014","line_url":"/filing/0001209191-07-042014#line-2","is_derivative":false,"issuer_cik":"0001087432","issuer_name":"INTERMUNE INC","issuer_ticker":"ITMN","issuer_name_source":null,"issuer_url":"/issuer/0001087432","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40763.0,"shares_display":"40,763","price_per_share":27.2735,"price_display":"27.27","price_state":"stated","total_value":1111749.6805,"total_display":"1,111,749.68","total_whole":"1,111,750","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-09","filed_date":"2007-07-11","scope":"insider"},{"id":7085004,"accession":"0001209191-07-041946","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-07-041946","line_url":"/filing/0001209191-07-041946","is_derivative":false,"issuer_cik":"0001087432","issuer_name":"INTERMUNE INC","issuer_ticker":"ITMN","issuer_name_source":null,"issuer_url":"/issuer/0001087432","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36609.0,"shares_display":"36,609","price_per_share":26.825,"price_display":"26.82","price_state":"stated","total_value":982036.425,"total_display":"982,036.42","total_whole":"982,036","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-06","filed_date":"2007-07-10","scope":"insider","n_lines":2},{"id":3735697,"accession":"0001209191-06-057355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-057355","line_url":"/filing/0001209191-06-057355#line-1","is_derivative":false,"issuer_cik":"0001087432","issuer_name":"INTERMUNE INC","issuer_ticker":"ITMN","issuer_name_source":null,"issuer_url":"/issuer/0001087432","owner_cik":"0001303811","owner_name":"Kassberg Thomas Richard","owner_display_name":"Kassberg Thomas Richard","owner_url":"/insider/0001303811","role":"Officer (SVP-Corp. Dev.& Comm. Oper)","role_mark":"O","role_mark_label":"Officer (SVP-Corp. Dev.& Comm. Oper)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP-Corp. Dev.& Comm. Oper.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1474.0,"shares_display":"1,474","price_per_share":22.06,"price_display":"22.06","price_state":"stated","total_value":32516.44,"total_display":"32,516.44","total_whole":"32,516","shares_owned_after":21907.0,"shares_owned_after_display":"21,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-11-01","filed_date":"2006-11-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":34,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":33,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":34},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001515673","name":"Ultragenyx Pharmaceutical Inc.","url":"/issuer/0001515673","role":"Officer (CBO & EVP)","n_filings":26,"first_seen":"2014-02-03","last_seen":"2025-03-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001087432","name":"INTERMUNE INC","url":"/issuer/0001087432","role":"Officer (SVP-Corp. Dev.& Comm. Oper), Other","n_filings":5,"first_seen":"2006-11-02","last_seen":"2007-12-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001303811","retrieved_at":"2026-08-27T07:15:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}